Hyperfine Inc Ordinary Shares - Class A HYPR 深 滬
已收盤 10-24 16:00:00 美东时间
1.28
+0.030
+2.40%
華盛通- 最 高1.32
- 今 開1.28
- 成交量 47.28万股
- 最 低 1.255
- 昨 收 1.25
- 總市值 1.01亿
- 52周最高 2.22
- 市盈率 靜 --
- 換手率 0.60%
- 52周最低 0.5327
- 委 比 -48.96%
- 總股本 7858.10万
- 歷史最高 16.61
- 量 比 0.45
- 振 幅 5.20%
- 歷史最低 0.5327
- 每 手 1
- 風險率 0.30%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Hyperfine Sees Q3 Sales $3.400M vs $3.507M Est
Hyperfine (NASDAQ:HYPR) sees Q3 sales of $3.400 million vs $3.507 million analyst estimate.
10-16 06:46
Hyperfine shares are trading lower after the company reported preliminary Q3 revenue results below estimates. Also, the company announced a proposed public offering.
Hyperfine shares are trading lower after the company reported preliminary Q3 re...
10-16 04:09
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers iSpecimen (NASDAQ:ISPC) shares rose 52.4% to $1.0 during Thursday's af...
09-05 05:13
Hyperfine Secures CE and UKCA Approvals For Optive AI, Advancing Image Quality For Portable MRI Across Europe
Approvals mark a major milestone and bring the most advanced image quality to date to Swoop® system users in European marketsHyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has
09-02 20:16
Hyperfine Inc. Reports Strong Growth Amid Strategic Advances
Hyperfine Inc. (($HYPR)) has held its Q2 earnings call. Read on for the main hi...
09-01 08:23
美股大行评级 | 潜在涨幅仍有782.74%！Passage BIO遭Canaccord Genuity下调目标价至67美元，维持"买入"评级
今日重点评级关注：Northland Capital Markets：维持BrainsWay"跑赢大市"评级，目标价从15美元升至19美元；Lake Street：维持Hyperfine"买入"评级，目标价从1.5美元升至2美元
08-15 09:30
Lake Street Maintains Buy on Hyperfine, Raises Price Target to $2
Lake Street analyst Frank Takkinen maintains Hyperfine (NASDAQ:HYPR) with a Buy and raises the price target from $1.5 to $2.
08-15 00:48
Hyperfine shares are trading higher. The company reported Q2 financial results.
Hyperfine shares are trading higher. The company reported Q2 financial results.
08-14 23:51
Hyperfine Affirms FY2025 Sales Guidance of $14.179M-$15.468M vs $14.193M Est
Hyperfine (NASDAQ:HYPR) affirms FY2025 sales outlook from $14.179 million-$15.468 million to $14.179 million-$15.468 million vs $14.193 million estimate.
08-14 04:07
Hyperfine Q2 EPS $(0.12), Inline, Sales $2.696M Miss $3.000M Estimate
Hyperfine (NASDAQ:HYPR) reported quarterly losses of $(0.12) per share which met the analyst consensus estimate. This is a 14.29 percent increase over losses of $(0.14) per share from the same period last year. The
08-14 04:06
